Cesarean section
Conditions
Interventions
Experiment group:ropivacaine (0.75%) was slowly infused into the subarachnoid space
Control group:bupivacaine (0.5%) was slowly infused into the subarachnoid space
Sponsors
Shengjing Hospital of China Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. ASAI-II level; 2. Age greater than or equal to 18 years old; 3. Cesarean section in Shengjing Hospital; 4. Single birth; 5. Full term (gestational age greater than or equal to 37 weeks).
Exclusion criteria
Exclusion criteria: 1. Contraindications to spinal anesthesia; 2. Hypersensitivity to Bubi or ropivacaine; 3. Maternal complications such as placenta accreta and other known cardiovascular diseases or diseases affecting hemodynamics; 4. The newborn has serious genetic disease or congenital disease; 5. Maternal weight 100 kg, height 180 cm.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiac output;Cardiac index; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood pressure;heart rate;Apgar score;Umbilical arterial blood gases;Motor block;Sensory block;phenylephrine use;Atropine use;Side-effects;Stroke volume;Stroke index;Ejection fraction;left ventricular end systolic volume;left ventricular end systolic volume index;left ventricular end diastolic volume;left ventricular end diastolic volume index; | — |
Countries
China
Contacts
Public ContactHaiyin Ji
Shengjing Hospital of China Medical University
Outcome results
None listed